학술논문
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis
Document Type
Correspondence
Source
In Autoimmunity Reviews July 2022 21(7)
Subject
Language
ISSN
1568-9972